Patents by Inventor Ernest Seidman

Ernest Seidman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF OPTIMIZING DRUG THERAPEUTIC EFFICACY FOR TREATMENT OF IMMUNE-MEDIATED GASTROINTESTINAL DISORDERS
    Publication number: 20070197461
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: March 21, 2007
    Publication date: August 23, 2007
    Applicant: Hopital Sainte-Justine
    Inventors: Ernest Seidman, Yves Theoret
  • METHODS OF OPTIMIZING DRUG THERAPEUTIC EFFICACY FOR TREATMENT OF IMMUNE-MEDIATED GASTROINTESTINAL DISORDERS
    Publication number: 20070197554
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: March 22, 2007
    Publication date: August 23, 2007
    Applicant: Hopital Sainte-Justine
    Inventors: Ernest Seidman, Yves Theoret
  • METHODS OF OPTIMIZING DRUG THERAPEUTIC EFFICACY FOR TREATMENT OF IMMUNE-MEDIATED GASTROINTESTINAL DISORDERS
    Publication number: 20060205084
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: May 26, 2006
    Publication date: September 14, 2006
    Applicant: Hôpital Sainte-Justine
    Inventors: Ernest Seidman, Yves Theoret
  • Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
    Publication number: 20050234078
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: June 14, 2005
    Publication date: October 20, 2005
    Applicant: Hopital Sainte-Justine
    Inventors: Ernest Seidman, Yves Theoret